APA (7th ed.) Citation

JK, J., FH, C., L, M., GJS, R., SA, S., R, G., . . . RA, H. (2022). Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 40(22), 2468. https://doi.org/10.1200/JCO.21.01199

Chicago Style (17th ed.) Citation

JK, Joffe, et al. "Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 40, no. 22 (2022): 2468. https://doi.org/10.1200/JCO.21.01199.

MLA (9th ed.) Citation

JK, Joffe, et al. "Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 40, no. 22, 2022, p. 2468, https://doi.org/10.1200/JCO.21.01199.